SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRII - Cell Robotics International, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sheetmillgalvanize who wrote (223)10/6/1999 10:33:00 AM
From: sheetmillgalvanize  Read Replies (1) of 252
 
Wednesday October 6, 8:12 am Eastern Time
Company Press Release
Cell Robotics Invited to RCG Growth Stock and CIBC World Markets Health Care Conferences
ALBUQUERQUE, N.M.--(BW HealthWire)--Oct. 6, 1999--Cell Robotics International Inc. (OTC BB: CRII) announces that it will be presenting at the RCG Growth Stock Conference Oct. 7 and 8, 1999, at the prestigious Phoenician Resort in Scottsdale, Ariz.

The Conference is designed specifically to provide leading emerging growth companies simultaneous exposure to the national investment community as well as the Wall Street and financial media panels and to provide each company with the undivided attention of the more than 250 attendees.

Cell Robotics' President and Chief Executive Officer, Ronald K. Lohrding, Ph.D., will be presenting at 2:15 p.m. on Thursday Oct. 7 and will be available along with Jean Scharf, Cell Robotics' CFO for individual discussions on both Oct. 7 and 8. Lohrding's presentation will be available on PR Newswire's web site (http://www.prnewswire.com) after Oct. 10, 1999.

Cell Robotics is also honored to be invited to participate in the 10th Annual CIBC World Markets (formerly CIBC Oppenheimer) Healthcare Conference, Oct. 25-27 at the Plaza Hotel in New York City.

This conference will feature more than 150 highly regarded companies in the health services, pharmaceutical, medical device and biotechnology industries. Last year the conference was attended by more than 1,000 institutional investors, healthcare executives and venture capitalists. Cell Robotics will be exhibiting at the Conference on Oct. 25 from 3:30 to 5:30 p.m.

Cell Robotics International Inc. developed and manufactures the Lasette(TM), a laser finger perforator that allows diabetics to sample their blood for glucose measurements in a nearly painless manner.

It also manufactures, markets, and sells the In Vitro Fertilization (IVF) Workstation (used in Laser Assisted Hatching and Zona Laser Treatment), and the Cell Robotics Workstation, a research instrument that incorporates the LaserTweezers© and LaserScissors(TM) for manipulating and cutting cells and chromosomes.

Additional information is available on the Cell Robotics Web Site, by e-mail at crii@cellrobotics.com, or by telephone at 505/343-1131.

Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the company's ability to execute its service and product sales plans; and the risks described from time to time in the company's Securities and Exchange Commission filings.

--------------------------------------------------------------------------------
Contact:

RCG Capital Markets Group Inc., 602/675-0400
Retail: Jim Estrada, Brett Maas
Analysts/Institutional: Joe Dorame
Media: Jeff Stanlis
www.rcgonline.com

--------------------------------------------------------------------------------
More Quotes and News: Cell Robotics International Inc (OTC BB:CRII.OB - news)
Related News Categories: computers, medical/pharmaceutical
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext